These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19590235)

  • 1. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
    Schumock GT; Andress DL; Marx SE; Sterz R; Joyce AT; Kalantar-Zadeh K
    Nephron Clin Pract; 2009; 113(1):c54-61. PubMed ID: 19590235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients.
    Schumock GT; Andress D; E Marx S; Sterz R; Joyce AT; Kalantar-Zadeh K
    Curr Med Res Opin; 2008 Nov; 24(11):3037-48. PubMed ID: 18826748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities.
    Khan S
    Nephron Clin Pract; 2007; 105(4):c159-64. PubMed ID: 17259740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up.
    Devins GM; Mendelssohn DC; Barré PE; Taub K; Binik YM
    Am J Kidney Dis; 2005 Dec; 46(6):1088-98. PubMed ID: 16310575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
    Chen JC; Kaul P; Levy JH; Haverich A; Menasché P; Smith PK; Carrier M; Verrier ED; Van de Werf F; Burge R; Finnegan P; Mark DB; Shernan SK;
    Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
    Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
    J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncomplicated acute renal failure and hospital resource utilization: a retrospective multicenter analysis.
    Fischer MJ; Brimhall BB; Lezotte DC; Glazner JE; Parikh CR
    Am J Kidney Dis; 2005 Dec; 46(6):1049-57. PubMed ID: 16310570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population.
    Baumeister SE; Böger CA; Krämer BK; Döring A; Eheberg D; Fischer B; John J; Koenig W; Meisinger C
    Am J Nephrol; 2010; 31(3):222-9. PubMed ID: 20068286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
    Coyne D; Acharya M; Qiu P; Abboud H; Batlle D; Rosansky S; Fadem S; Levine B; Williams L; Andress DL; Sprague SM
    Am J Kidney Dis; 2006 Feb; 47(2):263-76. PubMed ID: 16431255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HIV-infected patients' characteristics, healthcare resources use and cost between native and migrant patients.
    Wasserfallen JB; Hyjazi A; Cavassini M
    Int J Public Health; 2009; 54(1):5-10. PubMed ID: 19142582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.
    Lefebvre P; Duh MS; Buteau S; Bookhart B; Mody SH
    J Am Soc Nephrol; 2006 Dec; 17(12):3497-502. PubMed ID: 17082245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.
    Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimbürger O; Berglund L; Bárány P; Rutkowski B; Lindholm B; Stenvinkel P
    J Intern Med; 2009 Jun; 265(6):708-16. PubMed ID: 19298498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of disorders in mineral metabolism with progression of chronic kidney disease.
    Schwarz S; Trivedi BK; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):825-31. PubMed ID: 17699293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of nephropathy in diabetic patients in Germany in 2002.
    Happich M; Landgraf R; Piehlmeier W; Falkenstein P; Stamenitis S
    Diabetes Res Clin Pract; 2008 Apr; 80(1):34-9. PubMed ID: 18187227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.